X
API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
0
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
0
U.S. Medicaid
Annual Reports
0
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125118
https://www.clinicaltrialsarena.com/news/nih-covid-trial-survival/
https://www.expresspharma.in/immune-modulator-drugs-improves-survival-for-people-hospitalised-with-covid-19/
https://www.clinicaltrialsarena.com/news/bms-orencia-covid-trial/
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125118
https://www.fiercepharma.com/pharma/its-old-age-bristol-myers-orencia-becomes-first-drug-approved-for-preventing-graft-versus
https://www.fiercepharma.com/pharma/bristol-myers-nabs-priority-review-tag-for-3-15b-arthritis-drug-orencia-to-prevent
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125118
https://www.fiercepharma.com/marketing/abbvie-s-rinvoq-matches-bms-orencia-head-to-head-rheumatoid-arthritis-trial
https://news.abbvie.com/news/press-releases/abbvie-presents-data-showing-rinvoq-upadacitinib-meets-primary-and-key-secondary-endpoints-in-phase-3-head-to-head-study-versus-orencia-abatacept-in-rheumatoid-arthritis-patients.htm
https://news.bms.com/press-release/rd-news/bristol-myers-squibb-underscores-precision-focused-immunology-leadership-new-d
https://www.fiercebiotech.com/biotech/momenta-calls-time-biosimilar-r-d-cutting-half-its-staff?utm_source=internal&utm_medium=rss
Market Place
Share 
